Electric scooter rentals zoom into Moncton
'It blew up overnight,' said owner Steven MacArthur. 'We've had 400 to 500 rides every single day. We're excited to be here in Moncton, and the city loves it. There's 140 on the streets, and we're going to be launching another 100, we'll be around 240, 250 scooters on the streets. And we plan on getting more soon.'
The service is straightforward: download the app, add payment information and unlock a nearby scooter. These electric scooters offer a range of two to three hours of use, with some models capable of travelling up to 90 kilometres on a single charge.
'There is no target demographic,' MacArthur said. 'Everybody uses them pretty much between the age of 15 and 55. It can be, you know, a businessman trying to get to work. Or it could be a couple of teenagers at the university just going to have fun.
'You can rent it for, you know, five minutes, or you can rent it for two hours, however long the battery will last. For example, 12 bucks or 15 bucks, you get a bonus for adding money and a bonus for parking in certain spots. At the end of your ride, you park it safely off of sidewalks and roadways, take a quick picture of where you park it. It's called a park-approved photo, which will allow you to then end your ride and go about your day.'
Electric scooter on street
Move Scooter Rentals recently came to Moncton. (Source: Josh Smith/CTV News Atlantic)
Move Scooter Rentals relocated from Halifax due to a new bylaw. While currently operating in what MacArthur considers the off-season (June 1 to Oct. 31 is peak season), they're already seeing impressive usage.
'I think it has a lot to do with the layout of the city. People are using them more for travel. We're getting more 13-kilometre average rides instead of six-kilometre average rides in Halifax,' he said.
Patrick Richard, executive director of Downtown Moncton, welcomes the scooters but acknowledges some concerns.
'I think for the most part, they're happy that people are going to be getting around the downtown,' Richard said. 'There are some concerns that I would tend to agree with them about how they're kind of chaotically spread out throughout the downtown; they're not necessarily in one central area.
'I saw a lot of people after shows taking them from the Avenir, going to restaurants or getting across to St. George Street to go to a bar after hours, so that all of that is really exciting.'
MacArthur said his team is actively addressing concerns about scooter placement.
'We're just dealing with parking zones, working with businesses and people that don't want them parked there,' he said. 'And every time they send us an email, we respond right away or move the scooter.'
He also notes that theft is unlikely due to the scooters' GPS tracking.
'You get the odd person that thinks it's a good idea, but in the end, it's like stealing a cellphone,' MacArthur said. 'It just gets blacklisted. There's no way for the person to turn it on other than be connected to our app. So honestly? No point.'
For more New Brunswick news, visit our dedicated provincial page.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
35 minutes ago
- Globe and Mail
Is Chevron Stock a Buy Ahead of Q2 Earnings or Best to Wait?
Chevron CorporationCVX is slated to release second-quarter 2025 results on Aug. 1, before market open. The Zacks Consensus Estimate for the to-be-reported quarter's earnings per share (EPS) and revenues is pegged at $1.66 per share and $47.1 billion, respectively. The earnings estimates for the to-be-reported quarter have been revised upward by 5.1% over the past 30 days. The bottom-line projection indicates a decline of 34.9% from the year-ago reported number. The Zacks Consensus Estimate for quarterly revenues, meanwhile, suggests a year-over-year decrease of 7.9%. For full-year 2025, the Zacks Consensus Estimate for CVX's revenues is pegged at $191.5 billion, implying a decline of 5.6% year over year. The consensus mark for 2025 EPS stands at $7.26, indicating a contraction of around 27.8%. Image Source: Zacks Investment Research In the trailing four quarters, the San Ramon, CA-based oil and gas company surpassed EPS estimates twice and missed in the other two, as reflected in the chart below. Q2 Earnings Whispers for Chevron Our proven model predicts an earnings beat for Chevron this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter. CVX has an Earnings ESP of +3.63% and a Zacks Rank #3. You can see the complete list of today's Zacks #1 Rank stocks here. Natural Gas Strength to Aid CVX Q2 Results Let's start by exploring how Chevron's second-quarter results may have been shaped by fluctuations in oil and natural gas prices. According to the U.S. Energy Information Administration, average monthly WTI crude prices for April, May and June 2024 were $85.35, $80.02 and $79.77 per barrel, respectively. By comparison, prices declined to $63.54, $62.17, and $68.17 per barrel in the same order during the comparable months of 2025. This year-over-year drop highlights the weaker oil price environment in Q2 2025. As a matter of fact, ExxonMobilXOM, the world's largest integrated energy company, has already cautioned that its second-quarter earnings could take a hit because of lower oil prices. However, natural gas prices presented positive signals. In Q2 2025, U.S. Henry Hub average prices were $3.42 in April, $3.12 in May and $3.02 in June. These prices were significantly higher than the same months in 2024 — $1.60, $2.12 and $2.54, respectively. Chevron's production also offers an encouraging story. Output edged up 0.2% in the previous quarter, reflecting higher volumes from the Permian Basin, Kazakhstan and the Gulf of America, offset by asset sales in Canada and the Republic of Congo. For Q2 2025, Chevron's total production volume is estimated at 3,326 thousand barrels of oil-equivalent per day (MBOE/d), according to the Zacks Consensus Estimate. This is up from 3,292 MBOE/d churned out in the year-ago period. In particular, domestic natural gas production is likely to have been particularly strong, benefiting from a favorable price environment. The consensus mark for second-quarter U.S. gas output is 2,827 million cubic feet per day (MMcf/d) compared to 2,643 MMcf/d in the corresponding period of 2024. Chevron's 'Big Oil' peer BP plcBP also expects to pump out more oil and gas in the second quarter. This boost is largely thanks to higher output from BP's U.S. shale operations. However, BP has also warned that lower crude oil prices will hit its drilling profits hard. Coming back to Chevron, it might see a modest boost from its downstream/refining business, with margins going up. Consequently, the Zacks Consensus Estimate for CVX's second-quarter downstream income is pegged at $631 million, implying an improvement from $597 million earned in the year-ago period. ExxonMobil, too, indicated that refining profits could potentially add between $100 million and $500 million to its downstream profits. Meanwhile, BP anticipates refining profits jumping from $15.20 per barrel in the first quarter to $21.10 in the second. Price Performance & Valuation Over the past year, shares of Chevron have contracted more than 2%, underperforming the S&P 500. Image Source: Zacks Investment Research From a valuation perspective — in terms of forward price-to-earnings ratio — Chevron is trading at a premium compared to the industry average. The stock is also trading above its five-year mean of 11.86. Image Source: Zacks Investment Research How Should You Play CVX Pre-Q2 Earnings? Chevron heads into its second-quarter earnings report after recently concluding the Hess acquisition, secured after a lengthy dispute with ExxonMobil. The favorable ruling by an international arbitration panel puts an end to a long, drawn-out legal battle that had created tremendous uncertainty around one of the biggest oil deals in recent memory. A fully integrated energy firm, Chevron is positioned as one of the top global integrated oil firms, set for sustainable production growth, particularly due to its dominant position in the lucrative Permian Basin. Chevron's financial stability is also a key advantage. The company maintains a healthy balance sheet and continues to emphasize shareholder returns. With high dividend safety, Chevron returned billions in cash to investors even during oil price swings. This financial prudence supports long-term investor confidence. However, Chevron is faced with muted sales growth, which has been a driving force behind its poor share performance. Sales of $47.6 billion in the first quarter fell 2.3% year over year, which followed negative growth rates in some of the prior periods of the recent past. Meanwhile, pre-tax profit plunged 30% to $5.6 billion in Q1 due to a 3% rise in total costs. As a result, pre-tax margins narrowed significantly. This is especially concerning as Chevron shifts toward shorter-cycle, reinvestment-heavy shale projects to maintain production. So, all in all, now may not be the best time to buy the stock. It's wise to wait for Chevron's upcoming earnings to better gauge its 2025 outlook. CVX's premium valuation only adds to the case for caution. The market is also eager to see the company's initial thoughts on the landmark Hess deal, especially the impact it sees from the prized Guyana assets. Higher. Faster. Sooner. Buy These Stocks Now A small number of stocks are primed for a breakout, and you have a chance to get in before they take off. At any given time, there are only 220 Zacks Rank #1 Strong Buys. On average, this list more than doubles the S&P 500. We've combed through the latest Strong Buys and selected 7 compelling companies likely to jump sooner and climb higher than any other stock you could buy this month. You'll learn everything you need to know about these exciting trades in our brand-new Special Report, 7 Best Stocks for the Next 30 Days. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report This article originally published on Zacks Investment Research ( Zacks Investment Research
Cision Canada
3 hours ago
- Cision Canada
Avant Technologies and Ainnova Tech Advance Clinical Trial Protocol Following FDA Feedback
LAS VEGAS, July 29, 2025 /CNW/ -- Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging technology company developing healthcare solutions, and its Joint Venture partner, Ainnova Tech, Inc. (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced an update on the Company's clinical trial protocol following a recent pre-submission meeting with the U.S. Food and Drug Administration (FDA). Following its mid-July meeting with the FDA, Ainnova has revised its clinical trial protocol with the FDA's comments in mind. The new protocol will be resubmitted for FDA review to ensure compliance, which will mitigate potential costly errors in the development process for Ainnova's planned trial for its Vision AI platform in the early detection of diabetic retinopathy. Late last week, Ainnova's clinical development team met with Fortrea, the Company's Contract Research Organization, to present the updated protocol document. Upon approval, this protocol will pave the way for the initiation of a new clinical trial aligned with the revised guidelines. "We are committed to meeting the highest regulatory standards, and we're confident that these protocol refinements will strengthen our path toward FDA 510(k) clearance," said Vinicio Vargas, Chief Executive Officer at Ainnova and a member of the Board of Directors of Ai-nova Acquisition Corp. (AAC), the company formed by the partnership between Avant and Ainnova to advance and commercialize Ainnova's technology portfolio. "We anticipate finalizing the clinical trial budget soon, with estimated costs coming more into focus as we refine our protocol and navigate the process." The company remains focused on advancing its innovative Vision AI platform to address the early detection of diabetic retinopathy, with the goal of achieving FDA 510(k) approval to obtain clearance from the FDA to market its Vision AI technology in the U.S. and deliver transformative solutions to the market. AAC has the worldwide licensing rights for Ainnova's technology portfolio. The licensing rights include the U.S., where the FDA regulates drug and medical device development, so the success of Ainnova's clinical trial is paramount to marketing the technology portfolio in the United States. Entering the U.S. market will unlock significant commercial potential, and this early engagement with the FDA ensures AAC can do so with speed, credibility, and a validated product. About Ainnova Tech, Inc. Ainnova is a Nevada-based healthtech startup with headquarters in San Jose, Costa Rica, and Houston, Texas. Founded by an experienced and innovative team that is dedicated to leveraging artificial intelligence for early disease detection. Recognized with multiple global awards and renowned partnerships with hospitals and medical device companies, we proudly introduce Vision AI - our cutting-edge platform designed to prevent blindness and detect the early onset of diabetes. Explore how Ainnova is revolutionizing healthcare through advanced technology and proactive solutions. About Avant Technologies Inc. Avant Technologies Inc. is an emerging technology company developing solutions in healthcare using artificial intelligence and biotechnologies. With a focus on pushing the boundaries of what is possible in AI and biotechnology, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology. More information about Avant can be found at You can also follow us on social media at: Forward-Looking Statements Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date after the date of the press release.
Cision Canada
3 hours ago
- Cision Canada
Stay Home Forever Inc. Appoints Dane Clarke as First President and Chief Operating Officer
Industry leader brings culture-driven approach to Ontario-based homecare provider Stay Home Forever Inc. as he steps into the newly created role of President and Chief Operating Officer. TORONTO, July 29, 2025 /CNW/ - Stay Home Forever Inc. ("SHF"), a leading provider of private homecare services across Ontario, today announced the appointment of Dane Clarke as the President and Chief Operating Officer, effective immediately. To support its next phase of growth, SHF has created this new role, appointing Dane to lead operations and strategy while driving immediate impact with a culture-driven mission. Dane brings over 20 years of executive experience in healthcare operations, workforce strategy, and organizational growth. He has held leadership roles at CBI Health Group, Sinai Health Systems, and WSIB, leading initiatives that improved outcomes and expanded service delivery. Dane also played a key role in driving system-level change and navigating crisis response for healthcare organizations, including Ontario Health Teams (OHTs), co-chairing the Home Care Table during the covid-19 pandemic, and a key contributor to various initiatives and stakeholder engagements with Ontario Health. He attended the Ivey School of Business, reinforcing his ability to lead transformational change and cross-sector healthcare initiatives. "We are thrilled to welcome Dane to the SHF family," said Saye Sathiyakumar, CEO of Stay Home Forever Inc. "His proven leadership, deep industry knowledge, and passion for compassionate care align perfectly with our values. Dane's vision and operational expertise will be instrumental as we continue to scale our services and innovate in the homecare sector." "Joining Stay Home Forever is both a professional and personal calling," said Dane. "I look forward to working closely with Saye and the SHF team to strengthen our foundation, expand our services, and meet the growing need for culturally responsive care in Ontario." Dane's appointment reflects Stay Home Forever's identity as a proudly minority-owned company. As a second-generation Canadian, his personal experiences bring critical insight to a sector where much of the workforce shares similar backgrounds. His leadership helps ensure that the voices of underrepresented communities are reflected at every level of care. Stay Home Forever Inc. has earned a reputation for delivering personalized and client-centred care rooted in the belief that everyone deserves to live with dignity, comfort and connection. With Dane's leadership, SHF will continue to expand its tailored services and advance culturally responsive care for families across Ontario. About Stay Home Forever Inc. Founded in 2019, Stay Home Forever Inc. is a leading provider of private homecare services in Ontario. The company offers a comprehensive range of services - including personal care, companionship, nursing, and specialized support - all designed to promote independence and enhance quality of life. SHF is committed to delivering compassionate, reliable, and culturally appropriate care that meets the highest standards of excellence.
